These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 8983300)

  • 1. Single agent paclitaxel in the treatment of unresectable and/or metastatic pancreatic adenocarcinoma.
    Gebbia N; Gebbia V
    Eur J Cancer; 1996 Sep; 32A(10):1822-3. PubMed ID: 8983300
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase II trial of paclitaxel and granulocyte colony-stimulating factor in patients with pancreatic carcinoma: a Southwest Oncology Group study.
    Whitehead RP; Jacobson J; Brown TD; Taylor SA; Weiss GR; Macdonald JS
    J Clin Oncol; 1997 Jun; 15(6):2414-9. PubMed ID: 9196157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The winning formulation: the development of paclitaxel in pancreatic cancer.
    Ma WW; Hidalgo M
    Clin Cancer Res; 2013 Oct; 19(20):5572-9. PubMed ID: 23918602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperfractionated radiotherapy and paclitaxel for locally advanced/unresectable pancreatic cancer.
    Ashamalla H; Zaki B; Mokhtar B; Colella F; Selim H; Krishnamurthy M; Ross P
    Int J Radiat Oncol Biol Phys; 2003 Mar; 55(3):679-87. PubMed ID: 12573755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paclitaxel and concurrent radiation for locally advanced pancreatic cancer.
    Safran H; Moore T; Iannitti D; Dipetrillo T; Akerman P; Cioffi W; Harrington D; Quirk D; Rathore R; Cruff D; Vakharia J; Vora S; Savarese D; Wanebo H
    Int J Radiat Oncol Biol Phys; 2001 Apr; 49(5):1275-9. PubMed ID: 11286834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Irinotecan and paclitaxel in metastatic adenocarcinoma of the esophagus and gastric cardia.
    Hecht JR; Blanke CD; Benson AB; Lenz HJ
    Oncology (Williston Park); 2003 Sep; 17(9 Suppl 8):13-5. PubMed ID: 14569841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative paclitaxel and concurrent rapid-fractionation radiation for resectable pancreatic adenocarcinoma: toxicities, histologic response rates, and event-free outcome.
    Pisters PW; Wolff RA; Janjan NA; Cleary KR; Charnsangavej C; Crane CN; Lenzi R; Vauthey JN; Lee JE; Abbruzzese JL; Evans DB
    J Clin Oncol; 2002 May; 20(10):2537-44. PubMed ID: 12011133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paclitaxel and concurrent radiation therapy for locally advanced adenocarcinomas of the pancreas, stomach, and gastroesophageal junction.
    Safran H; Akerman P; Cioffi W; Gaissert H; Joseph P; King T; Hesketh PJ; Wanebo H
    Semin Radiat Oncol; 1999 Apr; 9(2 Suppl 1):53-7. PubMed ID: 10210540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paclitaxel in the treatment of patients with upper gastrointestinal carcinomas.
    Ajani JA; Ilson DH; Kelsen DP
    Semin Oncol; 1996 Oct; 23(5 Suppl 12):55-8. PubMed ID: 8941411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The activity of paclitaxel in gastrointestinal tumors.
    Ajani JA; Ilson DH; Kelsen DP
    Semin Oncol; 1995 Oct; 22(5 Suppl 12):46-50; discussion 51-3. PubMed ID: 7481861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nab-paclitaxel].
    Lopez-Trabada Ataz D; Dumont S; André T
    Bull Cancer; 2015 Jun; 102(6):568-76. PubMed ID: 26008630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Class III beta-tubulin, a marker of resistance to paclitaxel, is overexpressed in pancreatic ductal adenocarcinoma and intraepithelial neoplasia.
    Lee KM; Cao D; Itami A; Pour PM; Hruban RH; Maitra A; Ouellette MM
    Histopathology; 2007 Oct; 51(4):539-46. PubMed ID: 17714470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II study of paclitaxel therapy for unresectable biliary tree carcinomas.
    Jones DV; Lozano R; Hoque A; Markowitz A; Patt YZ
    J Clin Oncol; 1996 Aug; 14(8):2306-10. PubMed ID: 8708721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of pancreatic cancer with docetaxel and granulocyte colony-stimulating factor: a multicenter phase II study.
    Androulakis N; Kourousis C; Dimopoulos MA; Samelis G; Kakolyris S; Tsavaris N; Genatas K; Aravantinos G; Papadimitriou C; Karabekios S; Stathopoulos GP; Georgoulias V
    J Clin Oncol; 1999 Jun; 17(6):1779-85. PubMed ID: 10561215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II trial of outpatient schedule of paclitaxel in patients with previously untreated metastatic, measurable adenocarcinoma of the stomach.
    Garcia AA; Leichman CG; Lenz HJ; Baranda J; Lujan R; Casagrande Y; Leichman L
    Jpn J Clin Oncol; 2001 Jun; 31(6):275-8. PubMed ID: 11463806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Safety of Weekly Paclitaxel Therapy for Advanced Gastric Cancer Patients with Disseminated Intravascular Coagulation.
    Kawai S; Sakamoto Y; Takahashi Y; Ichikawa S; Gamoh M
    J Gastrointest Cancer; 2015 Dec; 46(4):438-41. PubMed ID: 26142346
    [No Abstract]   [Full Text] [Related]  

  • 17. [An early phase II clinical study of RP56976 (docetaxel) in patients with cancer of the gastrointestinal tract].
    Taguchi T
    Gan To Kagaku Ryoho; 1994 Oct; 21(14):2431-7. PubMed ID: 7944488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kaposi's sarcoma of the pancreas mimicking pancreatic cancer in an HIV-infected patient. Clinical diagnosis by detection of HHV 8 in bile and complete remission following antiviral and cytostatic therapy with paclitaxel.
    Menges M; Pees HW
    Int J Pancreatol; 1999 Dec; 26(3):193-9. PubMed ID: 10732297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Taxanes: impact on pancreatic cancer.
    Chiorean EG; Von Hoff DD
    Anticancer Drugs; 2014 May; 25(5):584-92. PubMed ID: 24463484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Albumin-bound paclitaxel plus gemcitabine in pancreatic cancer.
    Sahoo RK; Kumar L
    N Engl J Med; 2014 Jan; 370(5):478-9. PubMed ID: 24476440
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.